Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
Nventric has raised $22.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.
Nventric's investors include Premier Partners, Korea Development Bank, Shinhan Venture Investment, TIPS Program, Devsisters Ventures.
Nventric is headquartered in Arcadia, United States.
Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
Nventric is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nventric — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/nventric. Accessed August 13, 2026.
VCBacked. (2026). Nventric — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/nventric
{{cite web |title=Nventric — Funding & Investors |url=https://www.vcbacked.co/company/nventric |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated